|
Volumn 16, Issue 16, 2006, Pages 4400-4404
|
p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-d]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-d]pyrimidin-2-ones
|
Author keywords
Cellular and functional activity; Pyrimido pyrimidone; VX 745
|
Indexed keywords
3,4 DIHYDROPYRIDO[4,3 D]PYRIMIDIN 2 ONE;
3,4 DIHYDROPYRIMIDO [4,5 D]PYRIMIDIN 2 ONE;
ION CHANNEL;
MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR;
PIPERIDINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
PYRIMIDINONE DERIVATIVE;
QUINAZOLINONE DERIVATIVE;
UNCLASSIFIED DRUG;
ARTICLE;
ENZYME INHIBITION;
HUMAN;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
CHEMISTRY, PHARMACEUTICAL;
DRUG DESIGN;
ENZYME INHIBITORS;
HUMANS;
INHIBITORY CONCENTRATION 50;
MODELS, CHEMICAL;
P38 MITOGEN-ACTIVATED PROTEIN KINASES;
PYRIDAZINES;
PYRIDINES;
PYRIMIDINES;
PYRIMIDINONES;
QUINAZOLINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 33745699212
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2006.05.045 Document Type: Article |
Times cited : (13)
|
References (6)
|